Category



General Information

Locality: New York, New York

Phone: +1 212-566-5555



Address: 225 Varick St, Suite 402 10014 New York, NY, US

Website: www.aatod.org/

Likes: 1451

Reviews

Add review



Facebook Blog

AATOD 24.12.2020

Today is #GivingTuesday! December 1, 2020 is a global day of unity and generosity to contribute and make a difference for those who suffer from Opioid Use Disorder. During this challenging time, your donation will help us preserve patient confidentiality protections and continue to increase access to MAT in correctional settings and wherever treatment is needed throughout the world.... The American Association for the Treatment of Opioid Dependence, Inc. is a non-profit 501(c)(3) tax-exempt organization. Donations are 100% tax-deductible. Donate http://www.aatod.org/give/ https://lnkd.in/dDvU38Z

AATOD 12.12.2020

Early Registration Deadline: Sunday, November 1, 2020 Upcoming Conference Event #aatod2021 - Forging Partnerships to Improve Access to Quality Care ... The COVID-19 pandemic has changed the world and AATOD continues to evaluate our response to help mitigate risks and to do our part to prevent the spread of this virus. As we watch the developments of the COVID-19 pandemic, we are currently planning a hybrid model (live-in-person and virtual meeting) for the AATOD Conference, scheduled for April 10-14, 2021 in Las Vegas, Nevada. AATOD will continue to provide the world’s premier training and education event for the treatment of opioid use disorder. https://www.aatodconference.com

AATOD 30.10.2020

COVID-19 Impact Report and Video Summary As everyone knows, COVID-19 is still a major public health threat with terrible consequences. We are getting varying reports from low and high impact states but it is clear that wearing a mask is the principal preventative tool that we have prior to the release of a vaccine. For those of you that have been following us regarding COVID-19, we believe that you will find the AATOD's COVID-19 Impact Report to be of value. The information h...as been forwarded to SAMHSA and other federal agencies, which have jurisdiction in this area. The information was generated by AATOD Board members. It is now being shared with you and the entire field so that you can get a better sense of what we do know about the impact of COVID-19 on patients and programs. This is an update of where we are concerning extended take-home medication, toxicology reports, Personal Protective Equipment (PPE) for staff and a number of third-party billing issues. Executive Summary https://bit.ly/2IwUmp9 Full Report https://bit.ly/33YYqqh Video Summary https://lnkd.in/dF5xMdE

AATOD 23.10.2020

You are invited to view an informative and compelling opioid webinar in which national experts share their latest data to an audience of FL Drug Court Judges. ON-Demand: Trends in Opioid & Stimulant the Use in US - Potential Impact in Treatment Policy; Considerations for Courts (September 18, 2020) This Webinar included an update on COVID-19 impact on OTPs so that drug courts, their managers and staff have a better understanding of what to expect in making referrals to such t...reatment programs. There was also a discussion of pending policy issues, which will affect 4 OTP operations. The second part of the Webinar focused on general substance use trends throughout the United States as a method of informing drug courts and their staff on the potential impact of such trends on problem solving courts, including drug courts. Presenter & Moderator: Mark W. Parrino, M.P.A - President, AATOD - New York, American Association for the Treatment of Opioid Dependence. This presentation will focus on changing patient admission trends and policies within OTPs Presenter: Theodore J. Cicero, PhD, Professor Emeritus, Washington University School of Medicine in St. Louis. This presentation will focus on changing drug use trends in the United States. Presenter: Matthew Ellis, PhD(c), Research Faculty Instructor, Washington University in St. Louis The Florida Courts Opioid Initiative (FCO I), part of the Office of the State Courts Administrator, is hosting an online events series on the opioid epidemic. The series features national and state experts on a range of timely topics.

AATOD 19.10.2020

Mark Parrino, AATOD’s President, is honored to be a Stakeholder Board Member of the Justice Community Opioid Innovation Network (JCOIN), which re-envisions how the justice system responds to addiction. #nihHEALinitiative #JCOIN

AATOD 04.10.2020

For those of you who missed our criminal justice webinar today, we are delighted to share the recording with you -https://lnkd.in/dMU6iWF. "Increasing Access to MAT for OUD in the Criminal Justice Setting" This is one of the major policy initiatives for AATOD and we know that you will find the information to be of great value.... AATOD offered a criminal justice webinar which builds on the webinars that we have produced in the past as we steadily increase access to MAT in the correctional setting. Mark Parrino, AATOD President, introduced the webinar and served as its moderator and there were two featured speakers. Paul Samuels (President/Legal Action Center) focused on the work of the Legal Action Center in moving this policy forward. The LAC is one of the leading authorities in this area and they published a groundbreaking report in 2011 on this topic. Linda Hurley (CEO/CODAC) provided an update of the workings and achievements of her team's implementation of a successful OTP in the Rhode Island correctional system with the support of the State Opioid Treatment Authority and Department of Corrections. CODAC is the largest opioid treatment program system in RI and their model serves as one of the great success stories in this area. There was time for Q&A at the end of these presentations.

AATOD 19.09.2020

Join Us Wednesday, October 21 for a Complimentary Webinar.

AATOD 31.08.2020

A BIG CONGRATULATIONS to Holly Broce on her new promotion at Pinnacle Treatment Centers. Holly serves on the AATOD Board of Directors representing the state of Kentucky. Pinnacle Treatment Centers

AATOD 22.08.2020

EARLY REGISTRATION DEADLINE NOVEMBER 1, 2020 11:59 PM PST A Live and Virtual Conference aatodconference.com ***************... Message from Conference Chair I am writing on behalf of the AATOD Conference Committee to inform you that the early registration deadline of November 1, 2020 is nearing. The conference is focused on forging partnerships to improve access to quality care. Our conference comes at a time where the COVID-19 pandemic has changed the world and our response to help mitigate risks and do our part to prevent the spread of the virus. AATOD's hybrid model for the conference allows you to participate either live-in-person or virtually. Whichever option you select, be assured that AATOD will continue to offer information of innovative treatment techniques, evidence-based initiatives, and the opportunity to network with other professionals from around the world to effectively respond to the opioid crisis. The registration options (live-in-person/virtual) are transferable without penalty until the standard registration deadline, so go ahead and register now and save. For questions or additional information, please contact our conference management team via e-mail or call 856-423-3091. We look forward to welcoming you all to Las Vegas whether virtually or in-person, for an amazing experience. Las Vegas is one of the most exciting cities to visit and we hope you will join us on April 10-14, 2021 at the Venetian Hotel. Sincerely, Dinita Smith, MSW, LCADC 2021 AATOD Conference Chair

AATOD 13.08.2020

We would like to share a life-saving resource created by the The American Society of Anesthesiologists (ASA). ASA has created a card called Opioid Overdose Resuscitation which can be downloaded from the ASA website: https://bit.ly/2RI1bVW. We encourage the wide dissemination of this valuable card. #savinglives #opioidoverdose

AATOD 07.08.2020

AATOD in the news - Pulitzer Center on Crisis Reporting Anastassia Gliadkovskaya’s article captures a critical time during March and April of this year as Opioid Treatment Programs struggled to get Personal Protective Equipment (PPE), while rapidly adapting to the crisis of COVID-19. There are over 1,700 OTPs in the United States treating over 450,000 patients on any given day. Our treatment programs were fortunate to have the support of the Substance Abuse and Mental Health ...Services Administration (SAMHSA) and the Office of National Drug Control Policy (ONDCP) in having Opioid Treatment Programs declared as essential medical services. OTPs were then able to obtain PPE for their staff and critically needed sanitizers for the treatment programs. Zac Talbott National Alliance for Medication Assisted Recovery - NAMA Lakeland Centres Methadone Clinic https://pulitzercenter.org/reporting/how-politics-left-opioid-treatment-clinics-without-ppe-months

AATOD 02.08.2020

Would you like to know how states are encouraging, paying for or distributing Narcan kits? We encourage you to read NASADAD’s Overdose Reversal Analysis which includes reporting on the purchase and distribution of #naloxone. #opioidepidemic #overdoseprevention https://nasadad.org/wp-content/uploads/2020/04/STR_SOR_-Overdose-Reversal-.pdf

AATOD 18.07.2020

OKATOD will be hosting its 6th Annual Conference on September 25 - LEARNING FROM THE PAST: THE FUTURE OF OPIOID TREATMENT. In response to COVID-19, OKATOD will be presenting live and virtual participation to their attendees. OKATOD is a state chapter of AATOD and led by Ann Adams Jamieson . Guest speakers include AATOD’s President, Mark Parrino. Mark will discuss the current state of affairs of the opioid epidemic on a national level along with Carrie Slatton-Hodges, Oklahom...a Commissioner, who will be zooming in on impact of the opioid crisis in Oklahoma. Purchase your ticket https://bit.ly/33XFgio

AATOD 15.07.2020

19 years #neverforget

AATOD 28.06.2020

FINAL CALL FOR SUBMISSIONS #aatod2021 AATOD will continue to provide the world's premier training and education event for the treatment of Opioid Use Disorder. The 2021 AATOD Conference is a hybrid model, which will have virtual and onsite participation. As a potential presenter, you have the option to make your presentation either onsite or virtually. ... All interested parties should submit their presentations by tomorrow, September 11, 2020 by 11:59 PM PST. For more information and to submit a proposal www.aatodconference.com See more

AATOD 26.06.2020

Please join us on Thursday, September 10th at 3pm EST as we welcome FORE's COVID-19 National Emergency Response Webinar: OTP Clinician Perspectives on Methadone Service Delivery and the Use of Telemedicine during the COVID-19 Pandemic (9/10/2020).... During the COVID-19 pandemic, opioid treatment programs (OTPs) in the U.S. were granted new flexibility in methadone dispensing and the use of telemedicine. With a grant from FORE, the RAND Corporation explored the early impact of the pandemic and accompanying policy changes on service delivery, through semi-structured telephone interviews, asking OTP clinicians about changes in care patterns and perceptions of impacts on access and quality. This is an opportunity to begin to learn about the impact of the temporary regulatory and policy changes due to the pandemic public health emergency on OUD treatment delivery. Sarah Hunter, PhD, Senior Behavioral and Social Scientist, Professor, Pardee RAND Graduate School Lori Uscher-Pines, PhD, Senior Policy Research, Research Quality Assurance Manager, RAND Corporation as they share their findings on how the COVID-19 pandemic has altered the delivery of methadone treatment in the U.S.; Lawrence Brown, MD, MPH, FACP, DFASAM, Chief Executive Officer, START Treatment & Recovery Centers Lisa Brown, DNP, PMHNP-BC, FNP-NC, Family Nurse Practitioner and Psychiatric Mental Health Nurse Practitioner, E-Psychiatriq LLC as they share their experiences from the front-lines and how OTP changes have affected their practice and patients; and Mark Parrino, MPA, President, American Association for the Treatment of Opioid Dependence (AATOD) Betty Tai, PhD, Director, Center for Clinical Trials Network (CCTN), National Institute on Drug Abuse (NIDA) as they provide commentary on the current experiences of OTPs, and considerations for the future of these treatment systems.